Publications by authors named "Cheng-Chen Sun"

Claim this Profile
L
Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy: 48-week randomized, controlled, phase 3 non-inferiority TALENT study.
Bin Su, Cheng Yao, Qing-Xia Zhao, Wei-Ping Cai, Min Wang, Yong-Tao Sun, Li-Jun Sun, Cheng-Chen Sun

J Infectยท September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis